Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Tocilizumab

Roche’s Tocilizumab Fails to Meet Endpoints in Phase 3 COVACTA Trial, However, Does Cut COVID-19 Death Rate in RECOVERY Trial

The use of an immunosuppressive therapy known as tocilizumab, approved to treat the indication of rheumatoid arthritis, has been tested […]

Roche’s Tocilizumab Fails to Meet Endpoints in Phase 3 COVACTA Trial Does Cut COVID-19 Death Rate in RECOVERY Trial
1 week ago
Share

RECOVERY Trial Data Shows Roche Arthritis Drug Cuts Deaths in Hospitalized COVID-19 Patients

Roche’s arthritis drug tocilizumab cuts the risk of death among patients hospitalized with severe COVID-19, also shortening the time to […]

RECOVERY Trial Data Shows Roche Arthritis Drug Cuts Deaths in Hospitalized COVID-19 Patients
3 weeks ago
Share

Massachusetts General Hospital Completes Study & Concludes Tocilizumab Not Helpful for Hospitalized COVID-19 Patients

TrialSite has reported on a few different study results indicating that Roche’s Actemra (tocilizumab), an IL-6 inhibitor, doesn’t help to lower […]

Massachusetts General Hospital Completes Study & Concludes Tocilizumab Not Helpful for Hospitalized COVID-19 Patients
5 months ago
Share

Feinstein Institutes for Medical Research Breakthrough on How to Treat COVID-19 Cytokine Storm

Some patients’ immune systems have responded to SARS-CoV-2 infections by going into a form of overdrive, leading to the overzealous […]

Feinstein Institutes for Medical Research Breakthrough on How to Treat COVID-19 Cytokine Storm
5 months ago
Share

Rio Grande Valley Participates in Global COVID-19 Study via Valley Baptist Medical Center-Harlingen

Valley Baptist Medical Center-Harlingen, based in the Rio Grande Valley in Texas, was selected to participate in a clinical trial […]

Rio Grande Valley Participates in Global COVID-19 Study via Valley Baptist Medical Center-Harlingen
7 months ago
Share

Roche Confirms Tocilizumab (Actemra®) Failed to Meet Endpoints in the Phase 3 COVACTA Study Involving COVID-19 Associated Pneumonia

TrialSite recently suggested based on unfolding study results that repurposed IL-6 inhibitors, such as Roche’s Actemra®/ReActemtra® (tocilizumab), may not work to […]

Roche Confirms Tocilizumab (Actemra®) Failed to Meet Endpoints in the Phase 3 COVACTA Study Involving COVID-19 Associated Pneumonia
7 months ago
Share

India Approves Itolizumab & Tocilizumab for COVID-19: Controversy Commences over the Evidence while Demand Soars

200 mg vial Tocilizumab—15,000 Rs ($200.20)
400 mg vial Tocilizumab—30,000 Rs ($400.39)
Full Itolizumab Treatment—40,000 rupees

India Approves Itolizumab & Tocilizumab for COVID-19: Controversy Commences Over the Evidence while Demand Soars
8 months ago
Share

Baylor College of Medicine Joins Roche Study to Evaluate Tocilizumab in Severe SARS-CoV-2 Cases

Baylor College of Medicine is a clinical investigational site for a clinical trial investigating the therapeutic benefits of an immunomodulator […]

Baylor College of Medicine Joins Roche Study to Evaluate Tocilizumab in Severe SARS-CoV-2 Cases
10 months ago
Share

Genentech (Roche) Collaborates with BARDA to Launch Actemra Clinical Trial for Adult Patients with Severe COVID-19 Pneumonia

Genentech (Roche) plans a Phase III clinical trial to assess its marketed drug Actemra (tocilizumab) as a treatment for severe […]

Genentech (Roche) Collaborates with BARDA to Launch Actemra Clinical Trial for Adult Patients with Severe COVID-19 Pneumonia
12 months ago
Share

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.